AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

387 hedge funds and large institutions have $7.52B invested in Amedisys in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 136 increasing their positions, 151 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

12% less capital invested

Capital invested by funds: $8.52B → $7.52B (-$996M)

15% less call options, than puts

Call options by funds: $33.9M | Put options by funds: $40M

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
387
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33.9M
Puts
$40M
Net Calls
Net Calls Change

Top Buyers

1 +$93.9M
2 +$69.7M
3 +$61.5M
4
RP
Riverbridge Partners
Minnesota
+$47.3M
5
BlackRock
BlackRock
New York
+$32M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.09B
2
$827M
3
$428M
4
$409M
5
$309M
6
$245M
7
$243M
8
$211M
9
$200M
10
$198M
11
$167M
12
$121M
13
$117M
14
$115M
15
$106M
16
$97M
17
$96.1M
18
$91.3M
19
$90.5M
20
$84.6M
21
$79.4M
22
$75.2M
23
$71.3M
24
$67.4M
25
$66.5M